Clinical Trials Logo

Ovarian Neoplasms clinical trials

View clinical trials related to Ovarian Neoplasms.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06403072 Completed - Ovarian Cancer Clinical Trials

(GI-RADS) in Preoperative Evaluation of Adnexal Masses

Start date: June 1, 2021
Phase:
Study type: Observational

prospective study was conducted and performed on 100 women with pelvic pain due to accidently discovered adnexal mass

NCT ID: NCT06385912 Completed - Ovarian Cancer Clinical Trials

Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer

Start date: July 1, 2006
Phase:
Study type: Observational

The study aims to investigate the prognostic and postoperative complication relevance of lymphadenectomy in advanced epithelial ovarian cancer patients who received neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS). The main question it aims to answer is: Does systematic lymphadenectomy during interval debulking surgery have a significant impact on survival in patients with advanced epithelial ovarian cancer who have received neoadjuvant chemotherapy? The progression-free survival (PFS), overall survival (OS), and postoperative complication were compared between the lymphadenectomy and no lymphadenectomy groups to answer the question.

NCT ID: NCT06379191 Completed - Ovarian Cancer Clinical Trials

The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management Program

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

As the most malignant type of cancer in the female reproductive system, ovarian cancer (OC) has become the second leading cause of death among Chinese women. Chemotherapy is the main treatment for OC patients, and its numerous adverse effects can easily lead to malnutrition. It is difficult to centrally manage OC patients in the intervals between chemotherapy. The utility of WeChat, an effective and more cost-efficient mobile tool, in chronic disease management has been highlighted.

NCT ID: NCT06366997 Completed - Clinical trials for Epithelial Ovarian Cancer

Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test

Start date: October 9, 2019
Phase:
Study type: Observational

The study is designed to confirm the performance of the 3D Medicines Corporation OCS test in diagnosis of epithelial ovarian cancer in patients with adnexal mass. To this end, blood samples from female patients with adnexal mass required surgical resection from four centers are obtained and analysis in the study.

NCT ID: NCT06328491 Completed - Ovarian Cancer Clinical Trials

Erdafitinib in Metastatic Steroid-cell Ovarian Cancer

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

This is a single participant study of erdafitinib for the treatment of a patient with metastatic steroid-cell tumor of the ovary.

NCT ID: NCT06254781 Completed - Clinical trials for Adult Granulosa Cell Tumor of the Ovary

Luspatercept in Metastatic AGCT of the Ovary

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

This is a single participant study of luspatercept for the treatment of a patient with dult granulosa cell tumor (AGCT) of the ovary.

NCT ID: NCT06253559 Completed - Ovarian Cancer Clinical Trials

Clinical and Pathological Characteristics of Women With Ovarian Cancers in Syria

Start date: January 1, 2017
Phase:
Study type: Observational

the goal of this observational study is to describe ovarian cancer epidemiology and characteristics in Syrian women, especially during the war to do more research in the future about the risk factors of ovarian cancer.

NCT ID: NCT06201221 Completed - Clinical trials for Benign Ovarian Tumors

Single-port Laparoscopy in Children and Adolescents

Start date: January 1, 2019
Phase:
Study type: Observational

To compare the safety evaluation, efficacy evaluation, long-term aesthetics and psychological satisfaction of single-port and multiport laparoscopy for children and adolescents with BOT in China.

NCT ID: NCT06161233 Completed - Breast Cancer Clinical Trials

Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy

CAPABLE-IT
Start date: May 16, 2023
Phase: N/A
Study type: Interventional

The purpose of the CAPABLE study is to compare health-related quality of life in renal cell carcinoma patients who use or do not use a mobile-based application to monitor adverse events for cancer treatment at home. As secondary objectives, the study investigates the usability of the system and its generalizability to other cancer types

NCT ID: NCT06145295 Completed - Ovarian Cancer Clinical Trials

The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Background Ovarian cancer poses challenges for middle-aged and older patients, impacting physical and self-conceptual aspects. A research gap exists on the impact of online support groups (SPs) on identity synthesis and Health-Related Quality of Life (HRQOL) for these patients. Objective To assess the feasibility and efficacy of an online SG in influencing recovery identity and HRQOL in middle-aged and older ovarian cancer patients (MDOCP). Method A four-week randomized controlled trial, followed by a three-month evaluation, was conducted, employing a mobile online SG and an offline SG both grounded in The Social Identity Model of Identity Change. Recovery identity, HRQOL, and participant engagement were utilized to evaluate the feasibility and efficacy of interventions.